Panbela Therapeutics, Inc. today announced the pricing of a public offering of (i) 6,675,000 shares of its common stock (or pre-funded warrants in lieu thereof) and (ii) warrants to purchase up to 13,350,000 shares of its common stock.
January 26, 2023
· 8 min read